Abstract
Ceramide is a bioactive lipid involved in the induction of apoptosis and is the precursor to several sphingolipids, including sphingomyelin, the gangliosides, and sphingosine. Ceramide production is increased in response to stress and toxic agents. Because modulation of ceramide levels has been shown to affect sensitivity and/or resistance to therapeutic agents, it will be important to assess the activity of sphingolipid metabolic pathways when investigating the mode of action of antitumor drugs. This chapter summarizes protocols for quantitating the level of apoptosis, the activities of acidic sphingomyelinase, neutral sphingomyelinase, glycosylceramide synthase, sphingomyelin synthase, and ceramidase, and the amount of ceramide in tumor xenografts in nude mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jarvis, W. D. and Grant, S. (1998) The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol. 10, 552ā559.
Liu, G., Kleine, L., and Hebert, R. L. (1999) Advances in the signal transduction of ceramide and related sphingolipids. Crit. Rev. Clin. Lab. Sci. 36, 511ā573.
Pena, L. A., Fuks, Z., and Kolesnick, R. (1997) Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol. 53, 615ā621.
Levade, T. and Jaffrezou, J. P. (1999) Signalling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta 1438, 1ā17.
Liu, B., Obeid, L. M., and Hannun, Y. A. (1997) Sphingomyelinases in cell regulation. Semin. Cell Dev. Biol. 8, 311ā322.
Cabot, M. C., Giuliano, A. E., Han, T. Y., and Liu, Y. Y. (1999) SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drugresistant cancer cells. Cancer Res. 59, 880ā885.
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82, 405ā414.
Liu, Y. Y., Han, T. Y., Giuliano, A. E., and Cabot, M. C. (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274, 1140ā1146.
Senchenkov, A., Litvak, D. A., and Cabot, M. C. (2001) Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93, 347ā357.
Kolesnick, R. (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 110, 3ā8.
Modrak, D. E., Rodriguez, M. D., Goldenberg, D.M., Lew, W., and Blumenthal, R. D. (2002) Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int. J. Oncol. 20, 379ā384.
Merrill, A. and Hannun, Y. (eds.) (2000) Sphingolipid Metabolism and Cell Signalling, Part A, Vol. 311. Academic, London.
Merrill, A. and Hannun, Y. (eds.) (2000) Sphingolipid Metabolism and Cell Signalling, Part B, Vol. 312. Academic, London.
Hansen, H. J., Goldenberg, D. M., Newman, E. S., Grebenau, R., and Sharkey, R. M. (1993) Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer 71, 3478ā3485.
Bligh, E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911ā917.
Ames, B. N. (1966) Assay of inorganic phosphate, total phosphate and phosphatases. Meth. Enzymol. 8, 115ā118.
Bodennec, J., Brichon, G., Koul, O., El Babili, M., and Zwingelstein, G. (1997) A two-dimensional thin-layer chromatography procedure for simultaneous separation of ceramide and diacylglycerol species. J. Lipid Res. 38, 1702ā1706.
Morgan, E. T., Nikolova-Karakashian, M., Chen, J. Q., and Merrill, A. H. Jr. (1996) Sphingolipid-dependent signaling in regulation of cytochrome P450 expression. Meth. Enzymol. 272, 381ā388.
Watts, J. D., Gu, M., Polverino, A. J., Patterson, S. D., and Aebersold, R. (1997) Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc. Natl. Acad. Sci. USA 94, 7292ā7296.
Tepper, A. D. and Van Blitterswijk, W. J. (2000) Ceramide mass analysis by normalphase high-performance liquid chromatography. Meth. Enzymol. 312, 16ā22.
Liu, P. and Anderson, R. G. (1995) Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270, 27,179ā27,185.
Sillence, D. J., Raggers, R. J., and van Meer, G. (2000) Assays for transmembrane movement of sphingolipids. Meth. Enzymol. 312, 562ā579.
Liu, B. and Hannun, Y. A. (2000) Sphingomyelinase assay using radiolabeled substrate. Meth. Enzymol. 311, 164ā167.
Hertervig, E., Nilsson, A., Nyberg, L., and Duan, R. D. (1997) Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 79, 448ā453.
Shayman, J. A. and Abe, A. (2000) Glucosylceramide synthase: assay and properties. Meth. Enzymol. 311, 42ā49.
Nikolova-Karakashian, M. (2000) Assays for the biosynthesis of sphingomyelin and ceramide phosphoethanolamine. Meth. Enzymol. 311, 31ā42.
Nikolova-Karakashian, M. and Merrill, A. H. Jr. (2000) Ceramidases. Meth. Enzymol. 311, 194ā201.
Perry, D. K. and Hannun, Y. A. (1999) The use of diglyceride kinase for quantifying ceramide. Trends Biochem. Sci. 24, 226ā227.
Liu, B. and Hannun, Y. A. (1997)Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272, 16,281ā16,287.
Brenkert, A. and Radin, N. S. (1972) Synthesis of galactosyl ceramide and glucosyl ceramide by rat brain: assay procedures and changes with age. Brain Res. 36, 183ā193.
Shukla, G. S. and Radin, N. S. (1990) Glucosyceramide synthase of mouse kidney: further characterization with an improved assay method. Arch. Biochem. Biophys. 283, 372ā378.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Modrak, D.E. (2005). Measurement of Ceramide and Sphingolipid Metabolism in Tumors. In: Blumenthal, R.D. (eds) Chemosensitivity: Volume II. Methods in Molecular Medicineā¢, vol 111. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-889-7:183
Download citation
DOI: https://doi.org/10.1385/1-59259-889-7:183
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-586-6
Online ISBN: 978-1-59259-889-2
eBook Packages: Springer Protocols